Risk of Clinical Events in Presymptomatic Familial Cerebral Cavernous Malformations.

Authors

Constantina Rodica Popa, Dominique Hervé, Nassira Alili, Estelle Dubus, Abbas Taleb, Fanny Fernandes, Florence Riant, Elisabeth Tournier Lasserve, Louis Lambert, Hugues Chabriat, Stéphanie Guey

Published in

European journal of neurology. Volume 33. Issue 6. Pages e70669.

Abstract

Familial cerebral cavernous malformations (fCCM) may cause focal neurological deficits (FND) due to hemorrhagic or non-hemorrhagic events and epileptic seizures (ES). With the widespread use of magnetic resonance imaging (MRI) and genetic testing, diagnosis is now frequently established at a presymptomatic stage, before any clinical manifestation. However, the subsequent risk of a first clinical event in these individuals remains poorly defined.
We conducted a cohort-based analysis of retrospectively collected longitudinal data from 79 patients with fCCM who were asymptomatic at diagnosis (median age, 41.7 years) and managed in a national referral center.
Over 649.6 patient-years (median follow-up, 4.0 years), 23 patients (29%) experienced a first clinical event. Post-diagnostic event-free survival was approximately 97% at 1 year, 79% at 5 years, and 69% at 10 years. Incidence rates for a first event were 35.4 per 1000 person-years for any first event (FND or ES), 23.1 per 1000 person-years for a first FND, and 15.4 per 1000 person-years for a first ES. Male sex was independently associated with higher risk (HR 4.20; 95% CI, 1.60-11.04; p = 0.0036).
These data provide pragmatic post-diagnostic risk estimates to guide counseling and surveillance in asymptomatic fCCM.

PMID:
42334220
Bibliographic data and abstract were imported from PubMed on 23 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.